Drug reference
Pholcodine
Antitussive
Also known as 3-O-(2-morpholinoethyl) morphine
Antitussive
CDSCO approvedSchedule H
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Pholcodine is a centrally acting antitussive agent. Although structurally related to opioids, it has no opioid-like actions because the substitution at the 3-position is not removed by metabolism. It is effective in reducing the frequency and intensity of coughing.
Indications
Cough suppression (when cough does not serve a useful purpose, causes annoyance, prevents rest/sleep, or hinders medication adherence)Chronic cough contributing to fatiguecough suppressant (used clinically in many countries outside the U.S.)
Dosing
- Adult
- separate dose, total quantity, etc); . for liquids, the total volume in millilitres (in both words and figures) of the preparation to be supplied; for dosage units (tablets, capsules, ampoules), state the total number (in both words and figures) of dosage units to be supplied (e.g. 10 tablets [of 10 mg] rather than 100 mg total quantity); . the dose, which must be clearly defined (i.e.…
Pharmacokinetics
Half-life
Long
Metabolism
Substitution at the 3-position is not removed by metabolism
Related guidelines
Other Antitussive drugs
Ask House about Pholcodine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, BNF·Verified: 2026-05-13 · House clinical team